Health

CAR T-cell therapy has been a revolutionary advancement in cancer treatment, offering new hope to patients with refractory or relapsed malignancies. However, recent concerns have been raised regarding the incidence of second primary malignancies (SPM) associated with this therapy. A systematic literature review and meta-analysis aimed to evaluate the risk of SPM with CAR T-cell
0 Comments
A recent multicenter trial from Turkey has shed light on the effectiveness of immediately linking chronic obstructive pulmonary disease (COPD) and asthma patients who smoke to a smoking cessation clinic. The study, conducted by Dilek Karadogan, MD, at Recep Tayyip Erdoğan University, revealed promising results in terms of quit rates among participants. This article aims
0 Comments
In a rather peculiar turn of events, a hospitalized patient in Missouri was diagnosed with bird flu without any known contact with animals associated with the ongoing outbreak. This incident marks the 14th case of bird flu in the U.S. since March, when the virus was originally detected in cows, subsequently spreading to wild birds
0 Comments
The recent incident involving No. 1-ranked tennis player Jannik Sinner and his failed drug tests due to the use of an over-the-counter spray containing the banned anabolic steroid clostebol highlights the dangers and complexities surrounding the use of such medications in professional sports. Despite being cleared of any intentional wrongdoing, Sinner’s case sheds light on
0 Comments
The tragic death of Ugandan Olympic marathon runner Rebecca Cheptegei sheds light on a disturbing trend of violence against women. The fact that her own boyfriend reportedly poured gasoline on her and set her on fire is horrific and unacceptable. This kind of behavior highlights the urgent need for awareness and intervention to address domestic
0 Comments
Patients with inflammatory arthritis face challenges in finding effective treatments to manage their condition. A recent study conducted in Spain has shed light on the impact of biosimilar versions of etanercept and adalimumab on treatment retention for patients with inflammatory arthritis. The study compared the retention rates of patients who started either biosimilar or originator
0 Comments